[1] |
HU X M, LI P Y, GUO Y L, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia[J]. Stroke,2012,43(11):3063-3070. |
[2] |
HAN L J, CAI W, MAO L L, et al. Rosiglitazone promotes white matter integrity and long-term functional recovery after focal cerebral ischemia[J]. Stroke,2015,46(9):2628-2636. |
[3] |
XIONG X Y, LIU L, YANG Q W. Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke[J]. Prog Neurobiol,2016,142:23-44. |
[4] |
FUMAGALLI S, PEREGO C, PISCHIUTTA F, et al. The ischemic environment drives microglia and macrophage function[J]. Front Neurol,2015,6:81. |
[5] |
KIM B W, KOPPULA S, HONG S S, et al. Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathways[J]. PLoS One,2013,8(2):e55792. |
[6] |
MIRON V E, BOYD A, ZHAO J W, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination[J]. Nat Neurosci,2013,16(9):1211-1218. |
[7] |
BURMESTER G R, KREMER J M, VAN DEN BOSCH F, et al. Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial[J]. Lancet,2018,391(10139):2503-2512. |
[8] |
FLEISCHMANN R, PANGAN A L, SONG I H, et al. Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double-blind, randomized controlled trial[J]. Arthritis Rheumatol,2019,71(11):1788-1800. |
[9] |
杨宇. 乌帕替尼(Upadacitinib, Rinvoq)[J]. 中国药物化学杂志, 2020, 30(7):450. |
[10] |
SANDBORN W J, GHOSH S, PANES J, et al. Efficacy of upadacitinib in a randomized trial of patients with active ulcerative colitis[J]. Gastroenterology,2020,158(8):2139-2149.e14. |
[11] |
NADER A, STODTMANN S, FRIEDEL A, et al. Pharmacokinetics of upadacitinib in healthy subjects and subjects with rheumatoid arthritis, Crohn's disease, ulcerative colitis, or atopic dermatitis: population analyses of phase 1 and 2 clinical trials[J]. J Clin Pharmacol,2020,60(4):528-539. |
[12] |
LIU X R, LIU J, ZHAO S F, et al. Interleukin-4 is essential for microglia/macrophage M2 polarization and long-term recovery after cerebral ischemia[J]. Stroke,2016,47(2):498-504. |
[13] |
YANG X D, XU S Q, QIAN Y W, et al. Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury[J]. Brain Behav Immun,2017,64:162-172. |
[14] |
WYSS-CORAY T, MUCKE L. Inflammation in neurodegenerative disease: a double-edged sword[J]. Neuron,2002,35(3):419-432. |
[15] |
GLASS C K, SAIJO K, WINNER B, et al. Mechanisms underlying inflammation in neurodegeneration[J]. Cell,2010,140(6):918-934. |
[16] |
CHEN Z Q, YU H, LI H Y, et al. Negative regulation of glial Tim-3 inhibits the secretion of inflammatory factors and modulates microglia to antiinflammatory phenotype after experimental intracerebral hemorrhage in rats[J]. CNS Neurosci Ther,2019,25(6):674-684. |
[17] |
VILLARINO A V, KANNO Y, O'SHEA J J. Mechanisms and consequences of Jak-STAT signaling in the immune system[J]. Nat Immunol,2017,18(4):374-384. |
[18] |
GHORESCHI K, GADINA M. Jakpot! New small molecules in autoimmune and inflammatory diseases[J]. Exp Dermatol,2014,23(1):7-11. |
[19] |
SUNKARIA A, BHARDWAJ S, HALDER A, et al. Migration and phagocytic ability of activated microglia during post-natal development is mediated by calcium-dependent purinergic signalling[J]. Mol Neurobiol,2016,53(2):944-954. |
[20] |
ZHOU S J, ZHU W Q, ZHANG Y, et al. S100B promotes microglia M1 polarization and migration to aggravate cerebral ischemia[J]. Inflamm Res,2018,67(11-12):937-949. |